A pilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 1093-1098

  Iannitti, Tommaso ^a,b   Rottigni, V ^a,c   Palmieri, B ^a,c  

^a Poliambulatorio Del Secondo Parere   (Italy)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Hyaluronic acid; Osteoarthritis; Synvisc ; Variofill ; Viscosupplementation

Indexed keywords

HYALURONIC ACID; PARACETAMOL; UNCLASSIFIED DRUG; VARIOFILL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSS LINKING; DRUG EFFICACY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; VISCOSUPPLEMENTATION; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DISEASE DURATION; JOINT STIFFNESS; PAIN SEVERITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIPLE BLIND PROCEDURE;

EID: 84872921905     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500426     Document Type: Article

References (18)

1. Fox BA, Stephens MM. Glucosamine/chondroitin/primorine combination therapy for osteoarthritis. Drugs Today (Barc) 2009; 45(1):21-31.
2. Conrozier T, Chevalier X. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Expert Opin Pharmacother 2008; 9(10):1797-804.
3. Migliore A, Granata M, Tormenta S, et al. Hip viscosupplementation under ultra-sound guidance reduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry. Eur Rev Med Pharmacol Sci 2011; 15(1):25-34.
4. Iannitti T, Lodi D, Palmieri B. Intra-articular injections for the treatment of osteoarthritis: focus on the clinical use of hyaluronic acid. Drugs R D 2011; 11(1):13-27.
5. Chevalier X. Intraarticular treatments for osteoarthritis: new perspectives. Curr Drug Targets 2010; 11(5):546-60.
6. Fries JF. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal. J Rheumatol 1991; 28(S):6-10.
7. Rastogi S, Sharma VK, Chandra R, Sivaraman ST. Open Label Multicentre Trial on Safety and Efficacy of Intra-articular Hyaluronic acid in the Treatment of Osteoarthritis of the Knee - A prospective study. J Indian Acad Clin Med 2005; 6(3).
8. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16(2):137-62. (Pubitemid 351222155)
9. Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology 2007; 44(2):59-74. (Pubitemid 47356403)
10. Tikiz C, Unlu Z, Sener A, Efe M, Tuzun C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 2005; 24(3):244-50. (Pubitemid 40867947)
11. Alberto M, Umberto M, Emanuele B, Bruno L, Valentina G, Prisco P, Mauro G, Sandro T. Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne(R)) in symptomatic osteoarthritis of the hip: a prospective cohort study. Arch Orthop Trauma Surg 2011; 131(12):1677-85.
12. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993; 39(S):3-9.
13. Decaria J, Petrella R, Wolfe D, Chesworth BM, Montero-Odasso M. Effect of intra-articular hyaluronic acid on gait variability in older adults with knee osteoarthritis. J Am Geriatr Soc 2011; 59(5):949-51.
14. Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A, Della Bella G. A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil Med 2011; 47(3):407-15.
15. Ozturk C, Atamaz F, Hepguler S, Argin M, Arkun R. The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheumatol Int 2006; 26(4):314-9. (Pubitemid 43102472)
16. Migliore A, Giovannangeli F, Granata M, Lagana B. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010; 3:55-68.
17. Wang Y, Hall S, Hanna F, Wluka AE, Grant G, Marks P, Feletar M, Cicuttini FM. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord 2011; 12:195.
18. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16(4):494-502.